Miriam Provost, VP of US Regulatory & FDA Rel at TransMedics Group, Inc. (TMDX), sold 7,754 shares at $31.34 ($243K) on 2021-09-15, disclosed to the SEC on 2021-09-17.
Open-market sale of $243k TMDX by VP of US Regulatory & FDA Rel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.34 | 3,877 | $122K | 50.0% |
| 2 | $31.34 | 3,877 | $122K | 50.0% |
| Total | $31.34 avg | 7,754 | $243K | 100% |
| Filing → |
| TMDX | SELL | 2022-12-15 | $438K | — | Filing → |
| TMDX | SELL | 2022-12-13 | $213K | — | Filing → |